Cargando…

ACT-05 Present and future of precision-based medicine using cancer genome panels

Background: Two cancer genome panels were approved for use in Japan in 2019, and their application in brain tumors are awaited. We have used CANCERPLEXR and FoundationOne CDx (F1) panels for the realization of precision-based medicine in brain tumors. Patients and methods: From August 2017 to presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natsumeda, Manabu, Kanemaru, Yu, On, Jotaro, Saito, Shoji, Tsukamoto, Yoshihiro, Okada, Masayasu, Hiraishi, Tetsuya, Oishi, Makoto, Fujii, Yukihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699082/ http://dx.doi.org/10.1093/noajnl/vdaa143.034

Ejemplares similares

GEN-7 Liquid biopsy in brain tumor patients -The present and future-
por: Natsumeda, Manabu, et al.
Publicado: (2021)

STMO-16 The usability of Detailed pre-operative 3D simulation image for Tumor Resection of High grade glioma
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2021)

Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas
por: On, Jotaro, et al.
Publicado: (2021)

ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
por: Natsumeda, Manabu, et al.
Publicado: (2019)

ET-6 EFFICACY OF NEAR-INFRARED PHOTOIMMUNOTHERAPY TARGETING PODOPLANIN IN MALIGNANT GLIOMAS
por: Natsumeda, Manabu, et al.
Publicado: (2022)

Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide
por: Eda, Takeyoshi, et al.
Publicado: (2022)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019)

Meningoencephalocele in the Lateral Sphenoid Sinus Showing Malformation of Cortical Development: A Case Report
por: SATO, Taro, et al.
Publicado: (2022)

Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
por: Mouri, Yoshihiro, et al.
Publicado: (2022)

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
por: Kanemaru, Yu, et al.
Publicado: (2019)

EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma
por: NOZAWA, Takanori, et al.
Publicado: (2019)

Advantages of Dose-Dense Methotrexate Protocol for Primary Central Nervous System Lymphoma: Comparison of Two Different Protocols at a Single Institution
por: Aoki, Hiroshi, et al.
Publicado: (2013)

SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
por: Nakata, Satoshi, et al.
Publicado: (2022)

MBRS-06. Gli3 INDUCES NEURONAL DIFFERENTIATION IN WNT- AND SHH- ACTIVATED MEDULLOBLASTOMA
por: Natsumeda, Manabu, et al.
Publicado: (2020)

Preoperative three-dimensional multifusion imaging aiding successful microvascular decompression of a cerebellopontine angle lipoma: associated hemifacial spasm. Illustrative case
por: Seto, Hiroki, et al.
Publicado: (2023)

Less‐invasive diagnosis of disseminated epithelioid glioblastoma harboring BRAF V600E mutation by cerebrospinal fluid analysis—A case report
por: Natsumeda, Manabu, et al.
Publicado: (2021)

ML-09 The REAL-WORLD of Elderly PCNSL Therapy in Tohoku and Niigata Area According to Retrospective Analysis: A Collaborative Investigation of the Tohoku Brain Tumor Study Group
por: Asano, Kenichiro, et al.
Publicado: (2020)

Hemodynamic features of an intracranial aneurysm rupture predicted by perianeurysmal edema: A case report
por: Suzuki, Tomoaki, et al.
Publicado: (2021)

Monitoring of abnormal muscle response and facial motor evoked potential during microvascular decompression for hemifacial spasm
por: Fukuda, Masafumi, et al.
Publicado: (2012)

Characteristics of health-related quality of life and related factors in patients with brain tumors treated with rehabilitation therapy
por: Watanabe, Takahiro, et al.
Publicado: (2022)

CBMS-05 Biological and Pathological meaning of aneuploidy in mouse glioma stem sell
por: Negoto, Tetsuya, et al.
Publicado: (2020)

Synchronized multiple regression of diagnostic radiation-induced rather than spontaneous: disseminated primary intracranial germinoma in a woman: a case report
por: Yoneoka, Yuichiro, et al.
Publicado: (2011)

ACT-8 Current status and prospects for the treatment of malignant glioma using cancer gene panel tests
por: Koizumi, Shinichiro, et al.
Publicado: (2021)

Treatment Strategies for Infectious Intracranial Aneurysms: Report of Three Cases and Review of the Literature
por: ANDO, Kazuhiro, et al.
Publicado: (2019)

COT-05 Experience of fertility preservation in 3 male cases and 1 female case with high-grade glioma
por: Nakayama, Noriyuki, et al.
Publicado: (2020)

Novel devices for intraoperative monitoring of glossopharyngeal and vagus nerves during skull base surgery
por: Fukuda, Masafumi, et al.
Publicado: (2013)

Drainage patterns of the superficial middle cerebral vein: Effects on perioperative managements of petroclival meningioma
por: Fukuda, Masafumi, et al.
Publicado: (2015)

Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy
por: Natsumeda, Manabu, et al.
Publicado: (2014)

Detection of 2-Hydroxyglutarate by 3.0-Tesla Magnetic Resonance Spectroscopy in Gliomas with Rare IDH Mutations: Making Sense of “False-Positive” Cases
por: Natsumeda, Manabu, et al.
Publicado: (2021)

ACT-07 Clinical Trials of 11C-Methionine PET for brain tumors
por: Yamaguchi, Shigeru, et al.
Publicado: (2020)

ACT-17 Protocol design of a matrix-type of novel clinical trial for lower-grade gliomas
por: Muragaki, Yoshihiro, et al.
Publicado: (2020)

FSMP-05. KETOGENIC DIETS FOR HIGH-GRADE GLIOMA
por: Immidisetti, Amanda, et al.
Publicado: (2021)

BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022)

Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion
por: Bert, Jack, et al.
Publicado: (2018)

Clinical, imaging, and molecular features of radiation-induced glioblastomas developing more than 20 years after radiation therapy for intracranial germinomatous germ cell tumor: illustrative cases
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2023)

STMO-14 Clinical experience of brain tumor surgery using middleware “OPeLiNK”
por: Fujii, Yu, et al.
Publicado: (2021)

MBRS-32. TOPOISOMERASE II β INDUCES NEURONAL, BUT NOT GLIAL, DIFFERENTIATION IN MEDULLOBLASTOMA
por: Miyahara, Hiroaki, et al.
Publicado: (2020)

Possibility of Worsening Flow Diversion Effect Due to Morphological Changes of a Stented Artery With Multiple Overlapping Stents for Partially Thrombosed Vertebral Artery Aneurysms
por: Suzuki, Tomoaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h3imk1cnb0ou00tckgleskdc34